FocusDiagnostics

Does molecular monitoring matter in early-stage breast cancer?

See allHide authors and affiliations

Science Translational Medicine  26 Aug 2015:
Vol. 7, Issue 302, pp. 302fs35
DOI: 10.1126/scitranslmed.aac9445

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Serial monitoring of circulating tumor DNA predicts recurrence after treatment for localized breast cancer (Garcia-Murillas et al., this issue).

View Full Text